课题基金 / 基金详情

Molecular Genetics of HNPCC

Molecular Genetics of HNPCC
HNPCC 的分子遗传学
批准号:
6633111
负责人:
MARSHA L. FRAZIER
金额:
$43.97万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-06-01 至 2006-05-31

项目摘要

项目成果

MARSHA L. FRAZIER的其他基金

相似基金

相关文献

中文摘要
翻译
这项建议的总体目标是建立和扩大我们独特的遗传性非息肉病性结直肠癌(HNPCC)患者的临床和标本资源,以进一步阐明与HNPCC风险增加相关的遗传和表观遗传因素。将获得400名携带hMSH2或hMLH1基因胚系突变的受试者的流行病学数据。有人推测,在癌症风险中起次要作用的基因,即修饰基因,在预测HNPCC中的结直肠癌风险方面具有重要意义。将研究细胞周期基因如细胞周期蛋白d1、p53和p21的多态,以确定它们是否影响HNPCC的发病年龄。环境因素,特别是那些涉及叶酸途径和杂环胺摄入的因素将被研究,以确定它们是否与HNPCC的风险有关。我们将研究代谢基因如N-乙酰转移酶1、N-乙酰转移酶2、谷胱甘肽S转移酶M1、谷胱甘肽S转移酶T1等基因的多态性是否会影响HNPCC的发病年龄,然后结合膳食摄入量(重点是杂环胺)来确定这四个基因中的任何一个是否会影响HNPCC的发病年龄。我们将研究亚甲基四氢叶酸还原酶(MTHFR)基因677位密码子的多态性是否会影响HNPCC的发病年龄,然后结合饮食摄入数据(重点是叶酸)来确定它是否会影响HNPCC的发病年龄。模型将被开发来预测:1)携带MMR突变的个体发展为特定癌症的风险;以及II)给定发病年龄、MSI状态(如果已知)和家族病史,CRC患者发生MMR突变的概率。对于第一类模型,我们将使用新开发的亲属队列方法。为了预测个体是突变携带者的概率,我们将应用Logistic回归和分类回归树(CART)。这将是第一次对修饰基因在HNPCC中的作用进行大规模系统研究。拟议的研究将提供有关HNPCC中涉及结直肠癌发生的潜在遗传和表观遗传因素的重要信息,并有可能为可能影响这一过程的分子途径提供新的见解。
英文摘要
The overall goal of this proposal is to build upon and expand our unique clinical and specimen resource of hereditary non-polyposis colorectal cancer (HNPCC) patients to further elucidate genetic and epigenetic factors associated with increased risk for HNPCC. Epidemiologic data will be obtained on 400 subjects carrying germline mutations in either the hMSH2 or hMLH1 gene. It is hypothesized that genes playing minor roles in risk of cancer, modifier genes, are important in predicting risk of colorectal cancer in HNPCC. Polymorphisms in cell cycle genes such as cyclin D1, p53, and p21, will be studied to determine if they influence age of onset in HNPCC. Environmental factors, particularly those involving the folate pathway and heterocyclic amines intake will be studied to determine if they are associated with risk of HNPCC. Polymorphisms in metabolic genes such as N- Acetyltransferase 1 (NAT1), N-Acetyltransferase 2 (NAT2), Glutathione S-transferase M1 (GSTM1), Glutathione S-transferase T1 (GSTT1), will be studied to determine if they influence age of onset of HNPCC, and then to determine if any of the four genes, in combination with dietary intake data (with emphasis on heterocyclic amines) influence age of onset in HNPCC. A polymorphism of the Methylene tetrahydrofolate reductase (MTHFR) gene at codon 677 will be studied to determine if it influences age of onset of HNPCC, and then to determine in combination with dietary intake data (with emphasis on folate) if it influence age of onset of HNPCC. Models will be developed to predict i) the risk that an individual with MMR mutation will develop specific cancers and ii) the probability that a CRC patient will have a MMR mutation given the age at onset, MSI status (where known), and family history. For the first type of model, we will use the newly developed kin-cohort approach. To predict the probability that an individual is a mutation carrier, we will apply logistic regression and Classification and Regression Trees (CART). This will be the first large systematic study on the roles of modifier genes in HNPCC. The proposed studies will provide important information regarding underlying genetic and epigenetic factors involved in colorectal carcinogenesis in HNPCC and has the potential to provide novel insights into the molecular pathways that might influence this process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biospecimen Extraction
Mouse Model of Pancreatic Tumorigenesis with Dysregulation of mTOR
Biomarkers for the Early Detection of Pancreatic Cancer
Biomarkers for the Early Detection of Pancreatic Cancer
海外基金